ArticleCell death & disease2021

Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway.

Bingbing Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.